A Look at Current and Future Molecular Biomarkers in Locally Advanced and Metastatic Breast Cancers

The importance of molecular Biomarkers in Breast Cancer, current molecular biomarkers in HR+/HER2- mBC, and emerging molecular biomarkers in HR+/HER2- mBC.

• Appreciate the science and clinical applications of using molecular biomarkers to manage patients with breast cancer
• Recognize the current and emerging biomarkers that may influence clinical decision-making for patients with advanced breast cancer based on their prognostic and/or predictive value
• Understand the PI3K/AKT/PTEN pathway and its importance in HR+/HER2- metastatic breast cancer